HEB Stock Analysis July 6, 2009 7/6/09

HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for July 6, 2009

Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 7/6/09

Resistance Levels: $2.85, $3.00

Support Levels: $2.42, $2

Chart - http://stockcharts.com/

Discuss Stocks - http://stockstobuy.org/

Still waiting for FDA approval decision on Ampligen - HEB is back trading above the 10 day moving average but has failed to close back above $3. When this happens, you could see major spikes higher. HEB has only closed above $3 two times on this run, so a close above $3 would be huge technically. Pullbacks to the 50 day moving average can be bought unless the FDA rejects the Ampligen drug in which case HEB stock will go back under $1. For More Technical Analysis - Go Here

Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free